Detalhe da pesquisa
1.
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations.
Future Oncol
; 17(22): 2867-2881, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33866796
2.
Health and resource burden of a cancer diagnosis on the caregiver: an analysis of administrative claims data.
BMC Health Serv Res
; 21(1): 894, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461888
3.
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.
Cancers (Basel)
; 16(7)2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38611000
4.
Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.
J Gastric Cancer
; 23(2): 289-302, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129153
5.
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas.
Cancers (Basel)
; 15(19)2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835565
6.
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Cancers (Basel)
; 14(24)2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551611
7.
Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial.
Clin Cancer Res
; 27(14): 3861-3866, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632930
8.
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma.
Cancer Chemother Pharmacol
; 83(1): 191-199, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30406840
9.
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.
Clin Cancer Res
; 11(2 Pt 1): 690-6, 2005 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15701857
10.
Olaratumab-induced Biomarker Modulation in Sarcomas-Response.
Mol Cancer Ther
; 20(10): 2094, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607902
11.
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
J Clin Oncol
; 24(9): 1428-34, 2006 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16549837
12.
Robustness of an Adaptive Beamforming Method for Hearing Aids.
Acta Otolaryngol
; 109(sup469): 85-90, 1990.
Artigo
em Inglês
| MEDLINE | ID: mdl-31905525